BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17276388)

  • 1. Molecular pathways of angiogenesis inhibition.
    Tabruyn SP; Griffioen AW
    Biochem Biophys Res Commun; 2007 Mar; 355(1):1-5. PubMed ID: 17276388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring protein protects against rapid tumor growth.
    Future Oncol; 2005 Apr; 1(2):145. PubMed ID: 16555984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research advancement of endogenous angiogenesis inhibitors].
    Wu JX; Xu BL; Huang WL
    Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
    Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
    Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic approaches of angiogenesis inhibition: are we tackling the problem at the right level?
    Griffioen AW
    Trends Cardiovasc Med; 2007 Jul; 17(5):171-6. PubMed ID: 17574125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy in diabetic nephropathy.
    Zent R; Pozzi A
    J Am Soc Nephrol; 2006 Feb; 17(2):325-7. PubMed ID: 16434503
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and cancer: recent advances.
    Cáceres W; González S
    P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin.
    Folkman J
    Sci STKE; 2006 Sep; 2006(354):pe35. PubMed ID: 17003465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous angiogenesis inhibitors.
    Folkman J
    APMIS; 2004; 112(7-8):496-507. PubMed ID: 15563312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.
    Wang Z; Huang H
    Cancer Lett; 2013 May; 331(2):147-53. PubMed ID: 23337289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for a familiar protein in apoptosis induced by proteasome inhibition.
    McConkey DJ
    Cancer Cell; 2008 Jul; 14(1):1-2. PubMed ID: 18598936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the functions of endogenous angiogenesis inhibitors.
    Grant MA; Kalluri R
    Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.
    Cooke VG; Kalluri R
    Methods Enzymol; 2008; 444():1-19. PubMed ID: 19007658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways for cancer angioprevention.
    Albini A; Noonan DM; Ferrari N
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4320-5. PubMed ID: 17671111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatic proteins and peptides.
    Bouma-ter Steege JC; Mayo KH; Griffioen AW
    Crit Rev Eukaryot Gene Expr; 2001; 11(4):319-34. PubMed ID: 12067070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.